Eloxx Pharmaceuticals
Presence
Eloxx Pharmaceuticals is a company listed under the stock ticker ELOX (US).
Executives
View the org chart displaying its 7 main executives
Most searched biographies at Eloxx Pharmaceuticals
- Sumit Aggarwal, President, Chief Executive Officer
- Tomer Kariv, Chairman of the Board
- Alan Walts, Director
Create your alert
to follow the executive moves at Eloxx Pharmaceuticals.
Pharmaceuticals
Eloxx Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals Announces Changes to Board of Directors | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020 | Eloxx Pharmaceuticals, Inc.
- Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant | Eloxx Pharmaceuticals, Inc.
- Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October | Eloxx Pharmaceuticals, Inc.
- Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- View more press releases Close
Social media about Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Eloxx Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Lindsay Androski 
Call Eloxx Pharmaceuticals at +1 781...
